Details:

Alternative Title:
Emerg Infect Dis
Personal Author:
Cheng, Allen C. ; Turnidge, John ; Collignon, Peter ; Looke, David ; Barton, Mary ; ... More +
Cheng, Allen C. ; Turnidge, John ; Collignon, Peter ; Looke, David ; Barton, Mary ; Gottlieb, Thomas ; Less -
Description:
Fluoroquinolone antimicrobial drugs are highly bioavailable, broad-spectrum agents with activity against gram-negative pathogens, especially those resistant to other classes of antimicrobial drugs. Australia has restricted the use of quinolones in humans through its national pharmaceutical subsidy scheme; and, through regulation, has not permitted the use of quinolones in food-producing animals. As a consequence, resistance to fluoroquinolones in the community has been slow to emerge and has remained at low levels in key pathogens, such as Escherichia coli. In contrast to policies in most other countries, this policy has successfully preserved the utility of this class of antimicrobial drugs for treatment of most infections.
Subject:
[+]
Animal
Animals
Anti-Bacterial Agents
Antimicrobial Drug Resistance
Australia
Bacteria
Bacterial Drug Resistance
CME
Drug And Narcotic Control
Drug Prescriptions
Drug Resistance, Bacterial
Fluoroquinolones
Government Regulation
Health Policy
Human
Humans
Policy Review

Source:
Emerg Infect Dis. 18(9):1453-1460. ;
Document Type:
Journal Article ;
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:16d3332924364f9214c1a604f027469b03f082e9595cca76a49906f8a4cb5b15
File Type:

Supporting Files

• 	11-1515-F1.gif	gif
  	11-1515-F1.jpg	jpeg
  	11-1515-F2.gif	gif
  	11-1515-F2.jpg	jpeg
  	11-1515.nxml	txt
  	license.txt	txt

More +